EUVIMEDEUVIMED entdecken
Crossref

A novel tRNA-Derived fragment, tRF-20-M0NK5Y93 inhibits the malignant progression of non-small cell lung cancer by mediating PLOD1

Lixin Wu, Xiaojie Chen, Dong Chen, Qin Chen, Fengjie Wu

Archives of Biochemistry and Biophysics · 2025-08 · 770 · 110431

DOI: 10.1016/j.abb.2025.110431 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Archives of Biochemistry and Biophysics, 2025-08. Verfasst von Lixin Wu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory Medicine, Zhejiang Rongjun Hospital (The Third Affiliated Hospital of Jiaxing University), Jiaxing, 314000, Zhejiang, China. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, RNA, Transfer. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 43 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: Non-small cell lung cancer (NSCLC) constitutes a common malignant tumor characterized by substantial mortality rates. Transfer RNA (tRNA)-derived small RNAs (tsRNAs) have been implicated in the progression of various cancers, including NSCLC. However, to date, only a limited number of tsRNAs have been reported to be involved in the development of NSCLC. Hence, the present study aimed to investigate the potential roles of tsRNAs in the progression of NSCLC. MATERIALS AND METHODS: A total of forty-six patients with NSCLC who underwent surgical resection were enrolled in this study. The expression patterns of tRNA-derived fragments (tRFs) in tumor and normal tissues of 6 NSCLC cases were investigated using RNA-sequencing assay. Cell viability, proliferation capacity, and migratory ability were measured utilizing the CCK-8, colony formation, and Transwell assays, respectively. Furthermore, cell apoptosis was evaluated by applying flow cytometry. The xenograft tumor model was constructed to observe tumor growth. The relationship between tRF-20-M0NK5Y93 and PLOD1 was clarified using the luciferase and RIP assays. RESULTS: The RNA-sequencing assay revealed a significant decrease in the expression of tRF-20-M0NK5Y93 in tumor tissues. In line with this finding, qRT-PCR analysis further confirmed a meaningful downregulation of tRF-20-M0NK5Y93 in 46 patient samples with NSCLC. Importantly, this downregulated expression was strongly correlated with reduced patient survival. Additionally, overexpression of tRF-20-M0NK5Y93 was found to inhibit the proliferation and migration capabilities of NSCLC cells, leading to suppressed tumor growth and accelerated apoptosis. Furthermore, tRF-20-M0NK5Y93 was capable of binding to PLOD1, thereby negatively regulating its expression. Notably, the restoration of PLOD1 expression was able to counteract the inhibitory effects of enforced tRF-20-M0NK5Y93 on NSCLC cell proliferation, migration, and apoptosis. CONCLUSION: The expression level of tRF-20-M0NK5Y93 was found to be decreased in NSCLC. Overexpressed tRF-20-M0NK5Y93 exhibited inhibitory effects on NSCLC cell proliferation and migration, accelerated apoptosis, and suppressed tumor growth by targeting PLOD1. These findings highlight tRF-20-M0NK5Y93 as a promising target for NSCLC therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Non-Small-Cell LungLung NeoplasmsRNA, TransferHumansAnimalsCell ProliferationMiceFemaleMaleApoptosisCell MovementMice, NudeCell Line, TumorDisease ProgressionMiddle AgedGene Expression Regulation, NeoplasticMice, Inbred BALB C

Stichwörter der Autor:innen

ApoptosisMigrationNSCLCPLOD1ProliferationtRF-20-M0NK5Y93

Substanzen

RNA, Transfer

Autor:innen und Institutionen

  • Department of Respiratory Medicine, Zhejiang Rongjun Hospital (The Third Affiliated Hospital of Jiaxing University), Jiaxing, 314000, Zhejiang, China.
  • Department of Pathology, Zhejiang Rongjun Hospital (The Third Affiliated Hospital of Jiaxing University), Jiaxing, 314000, Zhejiang, China.
  • Department of Respiratory Medicine, Zhejiang Rongjun Hospital (The Third Affiliated Hospital of Jiaxing University), Jiaxing, 314000, Zhejiang, China. Electronic address: 501725167@qq.com.
  • Department of Respiratory Medicine, Jiaxing Hospital of Traditional Chinese Medicine, Jiaxing University, Jiaxing, 314000, Zhejiang, China. Electronic address: juedui820923@163.com.

Zitieren

APA

Wu, L., Chen, X., Chen, D., Chen, Q., & Wu, F. (2025). A novel tRNA-Derived fragment, tRF-20-M0NK5Y93 inhibits the malignant progression of non-small cell lung cancer by mediating PLOD1. Archives of Biochemistry and Biophysics, 770, 110431. https://doi.org/10.1016/j.abb.2025.110431

Vancouver

Wu L, Chen X, Chen D, Chen Q, Wu F. A novel tRNA-Derived fragment, tRF-20-M0NK5Y93 inhibits the malignant progression of non-small cell lung cancer by mediating PLOD1. Archives of Biochemistry and Biophysics. 2025;770:110431. doi:10.1016/j.abb.2025.110431

BibTeX
@article{Wu2025,
  author = {Wu, Lixin and Chen, Xiaojie and Chen, Dong and Chen, Qin and Wu, Fengjie},
  title = {A novel tRNA-Derived fragment, tRF-20-M0NK5Y93 inhibits the malignant progression of non-small cell lung cancer by mediating PLOD1},
  journal = {Archives of Biochemistry and Biophysics},
  year = {2025},
  volume = {770},
  pages = {110431},
  doi = {10.1016/j.abb.2025.110431}
}
Kostenlos starten →